Correlation of DNA ploidy and histologic diagnosis from prostate core- needle biopsies: Is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?

Journal of Surgical Oncology

Volumn 63, Issue 1, 1996, Pages 41-45

  Lo, Jeanne ^a   Kerns, Billie Jo ^a   Amling, Christopher L ^a   Robertson, C N ^a   Layfield, Lester J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

adenocarcinoma; core needle biopsy; DNA ploidy; prostate

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEEDLE BIOPSY; PLOIDY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATITIS;

ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; DNA, NEOPLASM; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLOIDIES; PROSTATE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0029828526     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199609)63:1<41::AID-JSO7>3.0.CO;2-Q     Document Type: Article

References (31)

1. Shankey TV, Kallioniemi O-P, Koslowski JM, Lieber ML, Mayall BH, Miller G, Smith GJ: Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 14:497-500, 1993.
2. Montgomery BT, Nativ O, Blute ML, Farrow GM, Myers RP, Zincke H, Lieber MM: Stage B prostatic adenocarcinoma: Flow cytometric nuclear DNA ploidy analysis. Arch Surg 125:327-331, 1990.
3. Nativ O, Winkler HZ, Raz Y, Themeau TM, Farrow GM, Myers RP, Zincke H, Lieber MM: Stage C prostatic adenocarcinoma: Flow cytometric nuclear DNA ploidy analysis. Mayo Clin Proc 64:911-919, 1989.
4. Winkler HZ, Rainwater LM, Myers RP, et al.: Stage D1 prostate adenocarcinoma: Significance of nuclear DNA ploidy patterns studied by flow cytometry. Mayo Clin Proc 63:103-112, 1988.
5. Blute ML, Nativ O, Zincke H, et al.: Pattern of failure often radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: Influence of tumor deoxyribonucleic acid ploidy. J Urol 142:1262-1265, 1989.
6. Stephenson RA, James BC, Gay H, Fair WR, Whitmore WF Jr, Melamod MR: Flow cytometry of prostate cancer: Relationship of DNA content to survival. Cancer Res 47:2504-2507, 1987.
7. Lundberg S, Carstensen J, Rundquist I: DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study. Cancer Res 47:1973-1977, 1987.
8. Fordham MV, Burdge H, Matthews J, Williams G, Cooke T: Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome. Br J Surg 73:400-403, 1986.
9. Bocking A, Chatelain R, Orthen U, Gien G, von Kalckreuth G, Jocham D, Wohltmann D: DNA grading of prostatic carcinoma: Prognostic validity and reproducibility. Anticancer Res 8:129-135, 1988.
10. al-Abadi H, Nagel R: Nuclear DNA analysis: The relevance of ploidy, DNA heterogeneity and phases of the cell cycle in 329 patients with prostatic carcinoma: A study on a follow-up of eight years. Urol Int 45:350-355, 1990.
11. Peters JM, Miles BJ, Kubus JJ, Crissman JD: Prognostic significance of the nuclear DNA content in localized prostatic adenocarcinoma. Anal Quant Cytol Histol 12:359-365, 1990.
12. Haugen QA, Mjolnerod O: DNA ploidy as a prognostic factor in prostatic carcinoma. Inter J Cancer 45:224-225, 1991.
13. Deiter SW, Cunningham R, Noguchi PD, et al.: Prognostic significance of the DNA ploidy in carcinoma of the prostate. Urology 33:361-366, 1989.
14. de Vere White RW, Deitch AD, Tesluk H, et al.: Prognosis in disseminated prostate cancer as related to tumor ploidy and differentiation. World J Urol 8:47-50, 1990.
15. Ritchie AW, Dorey F, Layfield LJ, Hannah J, Lovrekovich H, deKernion JB: Relationship of DNA content to conventional prognostic factors in clinically localized carcinoma of the prostate. Br J Urol 62:245-260, 1986.
16. Forsslund G, Zetterburg A: Ploidy level determinations in high grade and low-grade malignant variants of prostatic carcinoma. Cancer Res 60:4281-4285, 1990.
17. Forsslund G, Esposti PL, Nilsson B, Zetterburg A: The prognostic significance of nuclear DNA content in prostatic carcinoma. Cancer 69:1432-1439, 1992.
18. Nagel R, al Abad H: The prognostic significance of ploidy and DNA heterogenity in the primary diagnosis and monitoring of patients with locally advanced prostatic carcinoma. Scand J Urol Nephrol (Suppl) 138:83-92, 1991.
19. Song J, Cheng WS, Cupps RE, Earle JD, Farow GM, Lieber MM: Nuclear deoxyribonucleic acid content measured by static cytometry: Important prognostic association for patients with clinically localized prostate carcinoma treated by external beam radiotherapy. J Urol 147:794-797, 1992.
20. Zetterberg A, Esposti PL: Prognostic significance of nuclear DNA levels in prostatic carcinoma. Scand J Urol Nephrol (Suppl) 55:53-58, 1980.
21. Zetterberg A, Forsslund G: Ploidy level and tumor progression in prostatic carcinoma. Acta Oncologica 30:193-199, 1990.
22. Falkmer UG: Methodologic sources of errors in image and flow cytometric DNA assessments of the malignancy potential of prostatic carcinoma. Hum Pathol 23:360-367, 1992.
23. Jones EC, McNeal J, Bruchovsky N, et al.: DNA content in prostatic adenocarcinoma: A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage, Gleason grades 4 and 5, and lymph node metastases. Cancer 66:752-757, 1990.
24. Frankfurt OS, Chin JL, Englander LS, et al.: Relationship between DNA ploidy, glandular differentiation and tumor spread in human prostate cancer. Cancer Res 45:1418-1423, 1985.
25. Lee SE, Currin SM, Paulson DF, et al.: Flow cytometric determination of ploidy in prostatic adenocarcinoma: A comparison with seminal vesicle involvement in histopathological grading as a prediction of clinical recurrence. J Urol 140:769-774, 1988.
26. Stage R, Lundh B, Tribukait B, et al.: Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostatic specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma. J Urol 144:299-302, 1990.
27. Warzynski MJ, Soechtig CE, Maatman TJ, Goldsmith LC, Carothers GG: DNA analysis by flow cytometry of paraffin embedded core biopsies of the prostate. Prostate 24:313-319, 1994.
28. Leung CS, Zbieranowski I, Demers J, Murray D: DNA image cytometry of prostatic carcinoma of needle biopsy and subsequent prostatectomy specimens. Mod Pathol 7(2):195-199, 1994.
29. Falkner UG, Hagmar T, Auer GU: Efficacy of combined image and flow cytometric DNA assessments in human breast cancers: A methodological study based on routine histopathologic material of 2,024 excised tumor specimens. Anal Cell Pathol 2:297-312, 1990.
30. Fallenius A, Franzen S, Auer G: Predictive value of nuclear DA content in breast cancer in relation to clinical and morphologic factors: A retrospective study of 409 consecutive cases. Cancer 62:521-530, 1988.
31. Thorad E, Fosse S, Vaage S, et al.: Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics. Cancer 57:808-811, 1986.